The European Institute of Cancer Research develops, conducts, evaluates and publishes clinical and epidemiological studies either alone or in partnership with other health care institutions. In addition, the institute produces dossiers for early benefit assessments and benefit- or cost-benefit-assessments, as well as expert reports on drugs for regulatory agencies and other health institutions.